Pediatric-onset IBD is characterized by increasing incidence and prevalence, a comprehensive diagnostic workup, an extensive inflammatory phenotype compared to adult patients, and a risk of compromising important transitions from child to adult. On the therapeutic side, more options are available including new pharmaceutical-targeted drugs, nutritional therapy, and a combination of multimodal therapies, among others, to facilitate treatments targeting strategies for mucosal healing. Finding the right approach for every single patient early in the process is subject to studies from different fields and it can significantly contribute to improved quality of care, reduced costs, increased patient safety, and child health.
This Research Topic will focus on developments in pediatric-onset IBD to improve precision diagnosis, risk stratification, multimodal treatment, and new treatment concepts. It will cover empowering patients and their environment, improving the quality of care, and collecting real-world data close to the patient. Also, state-of-the-art technological innovation will be described including mHealth solutions, data integration approaches, wearables, big data, and artificial intelligence-based technology.
This Research Topic will include Original Research articles, Reviews, Mini Reviews, Systematic Reviews, Clinical Trials, Perspectives, Methods, Opinions, Curriculum, Instruction and Pedagogies, Brief Research Reports, and Technology and Codes from the field of basic and translational research, real-world data collection, health technology assessment and utilization, feasibility and proof of concept studies as well as health care structural and process development and evaluation. Patient participation and empowerment initiatives, as well as quality improvement initiatives, are also welcome.
Keywords:
pediatric-onset IBD, precision medicine, artificial intelligence, Crohn's disease, ulcerative colitis
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Pediatric-onset IBD is characterized by increasing incidence and prevalence, a comprehensive diagnostic workup, an extensive inflammatory phenotype compared to adult patients, and a risk of compromising important transitions from child to adult. On the therapeutic side, more options are available including new pharmaceutical-targeted drugs, nutritional therapy, and a combination of multimodal therapies, among others, to facilitate treatments targeting strategies for mucosal healing. Finding the right approach for every single patient early in the process is subject to studies from different fields and it can significantly contribute to improved quality of care, reduced costs, increased patient safety, and child health.
This Research Topic will focus on developments in pediatric-onset IBD to improve precision diagnosis, risk stratification, multimodal treatment, and new treatment concepts. It will cover empowering patients and their environment, improving the quality of care, and collecting real-world data close to the patient. Also, state-of-the-art technological innovation will be described including mHealth solutions, data integration approaches, wearables, big data, and artificial intelligence-based technology.
This Research Topic will include Original Research articles, Reviews, Mini Reviews, Systematic Reviews, Clinical Trials, Perspectives, Methods, Opinions, Curriculum, Instruction and Pedagogies, Brief Research Reports, and Technology and Codes from the field of basic and translational research, real-world data collection, health technology assessment and utilization, feasibility and proof of concept studies as well as health care structural and process development and evaluation. Patient participation and empowerment initiatives, as well as quality improvement initiatives, are also welcome.
Keywords:
pediatric-onset IBD, precision medicine, artificial intelligence, Crohn's disease, ulcerative colitis
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.